Ирина Александровна Балдуева
Institute of Oncology NN Petrov · 138 works · 276 citations · h-index 9
Top works
- Vemurafenib-induced progression of breast cancer: a case report and review of the literature
- Morphological Changes in Malignant Tumor Cells at Photodynamic Treatment Assessed by Digital Holographic Microscopy
- IPILIMUMAB IN PATIENTS WITH DISSEMINATED MELANOMA: THE N.N. PETROV NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY EXPANDED ACCESS PROGRAM EXPERIENCE
- Significant difference in response of malignant tumor cells of individual patients to photodynamic treatment as revealed by digital holographic microscopy
- Phase I/II trial of gene therapy with autologous tumor cells modified with tag7/PGRP-S gene in patients with disseminated solid tumors
- Radioprotective and radiomitigative effects of BP-C2, a novel lignin-derived polyphenolic composition with ammonium molybdate, in two mouse strains exposed to total body irradiation
- HOW APPROACHES TO DRUG THERAPY FOR MALIGNANT TUMORS HAVE CHANGED (TO THE FIRST DOMESTIC ANTITUMOR DRUG IS DEDICATED)
- Exploring bioactivity potential of polyphenolic water-soluble lignin derivative
- Cancer/testis antigens expression during cultivation of melanoma and soft tissue sarcoma cells
- Polyphenolic drug composition based on benzenepolycarboxylic acids (BP-C3) increases life span and inhibits spontaneous tumorigenesis in female SHR mice
- Peripheral blood lymphocyte changes after stereotactic ablative body radiotherapy to lung or liver metastases in patients with oligometastatic cancers
- The Effect of Polyphenolic Composition BP-C3 on the Efficacy and Hematological Toxicity of Cyclophosphamide in the Chemotherapy of Mice Bearing Soft Tissue Sarcomas Induced by Benzo[a]pyrene
- VARIETY OF TUMOR MODELS FOR TESTING ANTITUM TREATMENT ACTIVITY OF SUBSTANCES IN MICE
- Cell Technologies in Immunotherapy of Cancer
- Melatonin and Metformin Failed to Modify the Effect of Dacarbazine in Melanoma
- Results and prospects of development of new polyphenolic drugs for cancer patients
- Immunology and immunotherapy in the complex treatment of malignant tumors
- Ten-year experience of pharmacotherapy for soft tissue sarcomas
- Impact of the azoximer bromide concomitant therapy on outcomes in patients with soft tissue sarcoma.
- Impact of the azoximer bromide concomitant therapy on patient outcomes in patients with melanoma.